|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200055634 |
|
最近更新日期: Date of Last Refreshed on: |
2023-02-12 20:13:45 |
|
注册时间: Date of Registration: |
2022-01-15 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
Dr. Hanan Alomran, please upload ethical approval documents. 先天性肺叶过度充气是否需要常规手术干预?沙特阿拉伯利雅得一家三级医院的病例系列。 |
|
Public title: |
s surgical intervention routinely required for congenital lobar overinflation? A case series from a tertiary hospital in Riyadh, Saudi Arabia. |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
先天性肺叶过度充气是否需要常规手术干预?沙特阿拉伯利雅得一家三级医院的病例系列。 |
|
Scientific title: |
s surgical intervention routinely required for congenital lobar overinflation? A case series from a tertiary hospital in Riyadh, Saudi Arabia. |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
Hanan Alomran |
研究负责人: |
Hanan Alomran |
|
Applicant: |
Hanan Alomran |
Study leader: |
Hanan ALOmran |
|
申请注册联系人电话: Applicant telephone: |
0096611586100 |
研究负责人电话:
Study leader's |
0096611586100 |
|
申请注册联系人传真 : Applicant Fax: |
00966115886101 |
研究负责人传真: Study leader's fax: |
|
|
申请注册联系人电子邮件: Applicant E-mail: |
h.alomran@psau.edu.sa |
研究负责人电子邮件: Study leader's E-mail: |
h.alomran@psau.edu.sa |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
萨塔姆王子大学医学院 |
研究负责人通讯地址: |
萨塔姆王子大学医学院 |
|
Applicant address: |
prince Sattam univeristy, college of medicine |
Study leader's address: |
Prince Sattam University, College of Medicine |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
医学院儿科 |
||
|
Applicant's institution: |
college of medicine, pediatric department |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
C380/203/40 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
费萨尔国王专科医院研究中心伦理委员会 |
||
|
Name of the ethic committee: |
King Faisal Specialist Hospital Research Center Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-12-16 00:00:00 | ||
|
伦理委员会联系人: |
0114647272 |
||
|
Contact Name of the ethic committee: |
Rana Moslmani |
||
|
伦理委员会联系地址: |
沙特阿拉伯利雅得费萨尔国王专科医院研究中心。 |
||
|
Contact Address of the ethic committee: |
King Faisal Specialist Hospital Research Center, Riyadh, Saudi Arabia. |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
Pediatric Unit |
||||||||||||||||||||||
|
Primary sponsor: |
Hanan Alomran |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
沙特阿拉伯萨塔姆王子大学医学院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Prince Sattam University, College of Medicine, Saudi Arabia |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
没有资金来源。 |
||||||||||||||||||||||
|
Source(s) of funding: |
No funding sources. |
||||||||||||||||||||||
|
研究疾病: |
先天性肺叶过度充气 |
||||||||||||||||||||||
|
Target disease: |
Congenital lobar overinflation |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
在这项研究中,我们的目的是评估治疗轻度症状儿童先天性肺叶过度充气的保守方法。 由于对症状轻微的儿童采取保守治疗方法在肺科医生中并不常见。 |
||||||||||||||||||||||
|
Objectives of Study: |
In this study, our aim is to evaluate the conservative approach for treating mildly symptomatic children with congenital lobar overinflation. As the conservative approach for children with mild symptoms is not very common among pulmonologists. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
在一项病例系列研究中,我们回顾性地回顾了 2005 年 6 月至 2018 年 8 月期间在利雅得费萨尔国王专科医院和研究中心 (KFSHRC) 接受放射学诊断并接受保守治疗的 14 名患者的图表。 参与者初次到我们医院就诊时的年龄介于两天到四年之间。 对患者记录进行评估,包括其年龄、性别、临床表现、诊断和随访预约时的放射学检查结果、相关疾病和结果。 他们的平均随访时间为 53 个月(范围:4 个月至 10 年)。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
A case series study, we retrospectively reviewed the charts of 14 patients who had been diagnosed radiologically with CLO between June 2005 and August 2018 and treated conservatively at King Faisal Specialist Hospital and Research Center (KFSHRC) in Riyadh. Participants' age upon their initial presentation to our hospital ranged between two days to four years. Patients' records were evaluated regarding their age, gender, clinical presentations, radiological findings at the time of their diagnosis and follow-up appointments, associated diseases, and outcomes. Their mean follow-up duration was 53 months (range: 4 months to 10 years). |
||||||||||||||||||||||
|
纳入标准: |
所有在 2005 年 6 月至 2018 年 8 月期间被放射学诊断为先天性肺叶过度充气并在利雅得费萨尔国王专科医院和研究中心 (KFSHRC) 接受保守治疗的儿科患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
All pediatric patients who had been diagnosed radiologically with congenital lobar overinflation between June 2005 and August 2018 and treated conservatively at King Faisal Specialist Hospital and Research Center (KFSHRC) in Riyadh; |
||||||||||||||||||||||
|
排除标准: |
1. 明显呼吸窘迫、严重低氧血症、高碳酸血症; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Significant respiratory distress, severe hypoxemia, and hypercarbia; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2005-06-01 00:00:00至 To 2018-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2005-06-01 00:00:00 至 To 2018-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
观察性回顾性研究 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
observational retrospective study |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
Not stated |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not stated |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
在一项病例系列研究中,我们回顾性回顾了 2005 年 6 月至 2018 年 8 月期间放射学诊断为先天性肺叶过度充气并在利雅得费萨尔国王专科医院和研究中心 (KFSHRC) 接受保守治疗的 14 名患者的图表。 患者临床稳定,症状轻微(呼吸窘迫得到充分耐受),并且恢复良好。 参与者初次到我们医院就诊时的年龄介于两天到四年之间。 评估患者的记录,包括他们的年龄、性别、临床表现、诊断和随访预约时的放射学检查结果、相关疾病和结果。 他们的平均随访时间为 53 个月(范围:4 个月至 10 年)。 描述性统计用于总结我们的数据。 结果酌情表示为百分比、平均值和范围。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A case series study, we retrospectively reviewed the charts of 14 patients who had been diagnosed radiologically with congenital lobar overinflation in period between June 2005 and August 2018 and had been treated conservatively at King Faisal Specialist Hospital and Research Center (KFSHRC) in Riyadh. The patient is clinically stable with mild symptom (respiratory distress is adequately tolerated) and thriving well. Participants’ age upon their initial presentation to our hospital ranged between two days to four years. Patients’ records were evaluated regarding their age, gender, clinical presentations, radiological findings at the time of their diagnosis and follow-up appointments, associated diseases, and outcomes. Their mean follow-up duration was 53 months (range: 4 months to 10 years). Descriptive statistics were used to summarize our data. The results are expressed, as appropriate, as percentages, means, and ranges. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |